XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
CASH PROVIDED BY OPERATING ACTIVITIES:    
Net earnings $ 61,748 $ 39,195
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 16,662 16,446
Stock-based compensation arrangements 8,090 5,931
Deferred income taxes 222 4,574
Other, net (1,328) (6,696)
Decrease (Increase) in cash, net of acquisitions, resulting from changes in:    
Accounts receivable (25,771) 28,344
Inventories (17,472) (8,760)
Prepaid expenses and other current assets 1,944 1,331
Other assets 3,659 (477)
Accounts payable 26,019 (8,150)
Deferred revenue (4,531) 317
Accrued payroll and other liabilities (8,057) (14,760)
Accrued income taxes (1,722) (29,435)
Pension and other long-term liabilities (3,952) 15,316
Net cash provided by operating activities 55,511 43,176
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions to property and equipment, net (9,140) (7,099)
Proceeds from sale of assets 2,973 0
Proceeds from sale of business 0 25,920
Business acquisitions, net of cash acquired (579,556) (7,070)
Other investments (5,000) (9,500)
Net cash (used) provided by investing activities (590,723) 2,251
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from credit facility and long-term debt, including current portion 723,054 0
Repayments of credit facility 375,000 0
Repurchase of common stock (24,998) (94,956)
Dividends paid (23,031) (22,232)
Proceeds from shares issued pursuant to stock-based compensation plans 9,721 3,497
Payments Related to Tax Withholding for Share-based Compensation (1,013) (265)
Other financing activities (419) (11)
Net cash provided (used) by financing activities 308,314 (113,967)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (883) 1,588
Net decrease in cash and cash equivalents (227,781) (66,952)
Cash, cash equivalents and restricted cash, beginning of year 512,144 519,090
Cash, cash equivalents and restricted cash, end of period $ 284,363 $ 452,138